Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3646 AL 3660

A Comprehensive Update on Treatment of Dementia

Tisher A, Salardini A.

Semin Neurol. 2019 Apr;39(2):167-178. doi: 10.1055/s-0039-1683408. Epub 2019 Mar 29.

Vascular Cognitive Disorder

Paradise MB, Sachdev PS.

Semin Neurol. 2019 Apr;39(2):241-250. doi: 10.1055/s-0039-1678582. Epub 2019 Mar 29.

Frontotemporal Dementia: A Clinical Review

Sivasathiaseelan H, Marshall CR, Agustus JL, Benhamou E, Bond RL, van Leeuwen JEP, Hardy CJD, Rohrer JD, Warren JD.

Semin Neurol. 2019 Apr;39(2):251-263. doi: 10.1055/s-0039-1683379. Epub 2019 Mar 29.

The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study

Sachdev PS, Lipnicki DM, Crawford JD, Brodaty H.

Eur J Neurol. 2019 Sep;26(9):1161-1167. doi: 10.1111/ene.13960. Epub 2019 May 17.

The Potential of Actigraphy to Assess Agitation in Dementia

Rosenberg PB, Wanigatunga SK, Spira AP.

Am J Geriatr Psychiatry. 2019 Aug;27(8):870-872. doi: 10.1016/j.jagp.2019.03.009. Epub 2019 Mar 20.

Physical Activity Alleviates Cognitive Dysfunction of Alzheimer's Disease through Regulating the mTOR Signaling Pathway

Kou X, Chen D, Chen N.

Int J Mol Sci. 2019 Mar 29;20(7):1591. doi: 10.3390/ijms20071591.

Ambient Air Pollution, Noise, and Late-Life Cognitive Decline and Dementia Risk

Paul KC, Haan M, Mayeda ER, Ritz BR.

Annu Rev Public Health. 2019 Apr 1;40:203-220. doi: 10.1146/annurev-publhealth-040218-044058.

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study

Bunch TJ, Jacobs V, May H, Stevens SM, Crandall B, Cutler M, Day JD, Mallender C, Olson J, Osborn J, Weiss JP, Woller SC.

Clin Cardiol. 2019 May;42(5):506-512. doi: 10.1002/clc.23181. Epub 2019 Apr 10.

Amyloid PET and Changes in Clinical Management for Patients With Cognitive Impairment

Jack CR Jr, Petersen RC.

JAMA. 2019 Apr 2;321(13):1258-1260. doi: 10.1001/jama.2019.1998.

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC.

JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000.

Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment

Resnick B, Kolanowski A, Van Haitsma K, Galik E, Boltz M, Ellis J, Behrens L, Eshraghi K, Zhu S.

Clin Nurs Res. 2021 Jan;30(1):59-69. doi: 10.1177/1054773819838678. Epub 2019 Apr 3.

Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study

Bruce DG, Davis TME, Davis WA.

Acta Diabetol. 2019 Jul;56(7):767-776. doi: 10.1007/s00592-019-01322-9. Epub 2019 Apr 3.

Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease

McGrattan AM, McGuinness B, McKinley MC, Kee F, Passmore P, Woodside JV, McEvoy CT.

Curr Nutr Rep. 2019 Jun;8(2):53-65. doi: 10.1007/s13668-019-0271-4.

An urgent need to assess safe levels of inorganic copper in nutritional supplements/parenteral nutrition for subset of Alzheimer's disease patients

Kumar A, Sharma P, Prasad R, Pal A.

Neurotoxicology. 2019 Jul;73:168-174. doi: 10.1016/j.neuro.2019.04.001. Epub 2019 Apr 4.

The role of social and behavioral risk factors in explaining racial disparities in age-related cognitive impairment: a structured narrative review

Peterson RL, Fain MJ, A Butler E, Ehiri JE, Carvajal SC.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020 Mar;27(2):173-196. doi: 10.1080/13825585.2019.1598539. Epub 2019 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias